A mother whose attempted-suicide leap resulted in her 3-year-old daughter's death testified from bed Tuesday at her murder trial, saying she does not remember jumping or taking the girl with her.
"There was a rush and a voice that was telling me, "Do it. Do it.' It was an urge to kill myself," Farinoosh Dalili said. "I don't remember jumping."
Mrs. Dalili told of an arranged marriage to Nader Dalili, who she said pushed her down a flight of stairs when she was pregnant.
Mrs. Dalili, who has 200 pins holding her splintered bones together, has been watching the trial from a hospital bed because it is painful to sit up for long periods.
On March 3, 1997, she went to a hotel, requested a room on the highest floor and jumped out of the window, falling 10 floors.
The prosecution said she had her daughter in her arms. The defense said the child may have jumped after her mother.
Study says sponsor's drug
cuts heart attack risk
A study provides evidence that people with average cholesterol levels can substantially reduce their risk of heart attack by taking a drug that drives their cholesterol levels even lower.
The study, financed by Merck & Co. and reported extensively in November when preliminary findings were released, involved 6,605 middle-aged men and women, half of whom took Merck's expensive cholesterol-lowering drug, lovastatin; the rest took a placebo. After five years, those who had taken lovastatin had 37 percent fewer heart attacks and other serious signs of heart disease than those who had taken the placebo.
In their paper, published today in the Journal of the American Medical Association, the authors said that if the study's findings were put into practice, the eligible U.S. population for cholesterol-lowering drugs would triple, going from today's 2-million to 6-million.